BACKGROUND: End-of-life care (EOLC) discussions and decisions are common in pediatric oncology. Interracial differences have been identified in adult EOLC preferences, but the relation of race to EOLC in pediatric oncology has not been reported. We assessed whether race (white, black) was associated with the frequency of do-not-resuscitate (DNR) orders, the number and timing of EOLC discussions, or the timing of EOLC decisions among patients treated at our institution who died. METHODS: We reviewed the records of 380 patients who died between July 1, 2001 and February 28, 2005. Chi(2) and Wilcoxon rank-sum tests were used to test the association of race with the number and timing of EOLC discussions, the number of DNR changes, the timing of EOLC decisions (i.e., DNR order, hospice referral), and the presence of a DNR order at the time of death. These analyses were limited to the 345 patients who self-identified as black or white. RESULTS: We found no association between race and DNR status at the time of death (p = 0.57), the proportion of patients with DNR order changes (p = 0.82), the median time from DNR order to death (p = 0.51), the time from first EOLC discussion to DNR order (p = 0.12), the time from first EOLC discussion to death (p = 0.33), the proportion of patients who enrolled in hospice (p = 0.64), the time from hospice enrollment to death (p = 0.2) or the number of EOLC discussions before a DNR decision (p = 0.48). CONCLUSION: When equal access to specialized pediatric cancer care is provided, race is not a significant factor in the presence or timing of a DNR order, enrollment in or timing of enrollment in hospice, or the number or timing of EOLC discussions before death.
BACKGROUND: End-of-life care (EOLC) discussions and decisions are common in pediatric oncology. Interracial differences have been identified in adult EOLC preferences, but the relation of race to EOLC in pediatric oncology has not been reported. We assessed whether race (white, black) was associated with the frequency of do-not-resuscitate (DNR) orders, the number and timing of EOLC discussions, or the timing of EOLC decisions among patients treated at our institution who died. METHODS: We reviewed the records of 380 patients who died between July 1, 2001 and February 28, 2005. Chi(2) and Wilcoxon rank-sum tests were used to test the association of race with the number and timing of EOLC discussions, the number of DNR changes, the timing of EOLC decisions (i.e., DNR order, hospice referral), and the presence of a DNR order at the time of death. These analyses were limited to the 345 patients who self-identified as black or white. RESULTS: We found no association between race and DNR status at the time of death (p = 0.57), the proportion of patients with DNR order changes (p = 0.82), the median time from DNR order to death (p = 0.51), the time from first EOLC discussion to DNR order (p = 0.12), the time from first EOLC discussion to death (p = 0.33), the proportion of patients who enrolled in hospice (p = 0.64), the time from hospice enrollment to death (p = 0.2) or the number of EOLC discussions before a DNR decision (p = 0.48). CONCLUSION: When equal access to specialized pediatric cancer care is provided, race is not a significant factor in the presence or timing of a DNR order, enrollment in or timing of enrollment in hospice, or the number or timing of EOLC discussions before death.
Authors: W A Bleyer; H A Tejeda; S B Murphy; O W Brawley; M A Smith; R S Ungerleider Journal: J Pediatr Hematol Oncol Date: 1997 Sep-Oct Impact factor: 1.289
Authors: P S Hinds; L Oakes; W Furman; P Foppiano; M S Olson; A Quargnenti; J Gattuso; B Powell; D K Srivastava; D Jayawardene; J T Sandlund; C Strong Journal: Oncol Nurs Forum Date: 1997-10 Impact factor: 2.172
Authors: Pamela S Hinds; Donna Drew; Linda L Oakes; Maryam Fouladi; Sheri L Spunt; Christopher Church; Wayne L Furman Journal: J Clin Oncol Date: 2005-09-19 Impact factor: 44.544
Authors: Ellen B Clarke; J Randall Curtis; John M Luce; Mitchell Levy; Marion Danis; Judith Nelson; Mildred Z Solomon Journal: Crit Care Med Date: 2003-09 Impact factor: 7.598
Authors: Christian Simon; Stephen J Zyzanski; Michelle Eder; Pauline Raiz; Eric D Kodish; Laura A Siminoff Journal: J Clin Oncol Date: 2003-06-01 Impact factor: 44.544
Authors: Pamela S Hinds; Linda L Oakes; Judy Hicks; Brent Powell; Deo Kumar Srivastava; Justin N Baker; Sheri L Spunt; Nancy K West; Wayne L Furman Journal: J Palliat Med Date: 2012-06-26 Impact factor: 2.947
Authors: Erica C Kaye; Jonathan Jerkins; Courtney A Gushue; Samantha DeMarsh; April Sykes; Zhaohua Lu; Jennifer M Snaman; Lindsay Blazin; Liza-Marie Johnson; Deena R Levine; R Ray Morrison; Justin N Baker Journal: J Pain Symptom Manage Date: 2018-02-08 Impact factor: 3.612
Authors: Deena R Levine; Liza-Marie Johnson; Belinda N Mandrell; Jie Yang; Nancy K West; Pamela S Hinds; Justin N Baker Journal: Cancer Date: 2014-12-29 Impact factor: 6.860
Authors: Erica C Kaye; Courtney A Gushue; Samantha DeMarsh; Jonathan Jerkins; April Sykes; Zhaohua Lu; Jennifer M Snaman; Lindsay Blazin; Liza-Marie Johnson; Deena R Levine; R Ray Morrison; Justin N Baker Journal: Pediatr Blood Cancer Date: 2017-12-08 Impact factor: 3.167
Authors: Erica C Kaye; Samantha DeMarsh; Courtney A Gushue; Jonathan Jerkins; April Sykes; Zhaohua Lu; Jennifer M Snaman; Lindsay J Blazin; Liza-Marie Johnson; Deena R Levine; R Ray Morrison; Justin N Baker Journal: Oncologist Date: 2018-05-04